胡战;方颖;
HU Zhan;FANG Ying;Guizhou Medical University;

• 1:贵州医科大学

摘要(Abstract)：

目的:通过检测不同程度冠状动脉狭窄患者的维生素D水平及血压、体重指数(BMI)、血糖、血脂等冠心病危险因素,探讨维生素D水平与冠心病的相关性。方法:179例拟诊为冠心病患者,根据冠脉造影结果分为冠脉正常组、冠状动脉粥样硬化症组及冠心病组,记录3组患者年龄、体重指数等一般资料,检测血压、血糖、血脂、25(OH)D水平;多重回归分析Vit D与冠状动脉粥样硬化危险因素的相关性。结果:实验组与对照组间血清维生素D浓度对比差异有统计学意义(P<0.05);多重线性回归分析显示,血清维生素D水平与冠状动脉狭窄程度呈负相关(r=-0.023、-0.882,P<0.05);维生素D与高血压病、2型糖尿病、胆固醇、甘油三脂、体重指数呈负相关(r=-0.206、-0.209、-0.287、-0.439,P<0.05)。结论:维生素D可能为冠心病的危险因素。
Objective: To investigate different levels of vitamin D levels,blood pressure,body mass index( BMI),blood glucose,blood lipid of coronary artery stenosis patients to explore the correlation between vitamin D levels and coronary heart disease and its risk factors. Methods: A total of 179 patients diagnosed with different degrees of coronary artery stenosis were divided into normal group,coronary atherosclerosis group and coronary heart disease group according to CAG results. Recording patients' age,weight,blood pressure,blood glucose,lipid levels and 25( OH) D level. Multi regression analysis was conducted to analyze the correlation between vitamin D and coronary atherosclerosis. Results: Serum vitamin D concentration contrast between experimental and control groups were statistically significant( P < 0. 05). Multiple linear regression analysis showed that vitamin D level is negative correlated to the degree of coronary artery stenosis( r =-0. 023、-0. 882,P < 0. 05); Vitamin D showed negative correlation with hypertension,type 2 diabetes,total cholesterol,triglyceride,body mass index( r =-0. 206,-0. 209,-0. 287,-0. 439,P < 0. 05). Conclusion: The vitamin D could be the risk factors of coronary heart disease.

关键词(KeyWords)： 维生素D;冠心病危险因素;冠状动脉粥样硬化;狭窄程度;冠脉造影
vitamin D;the risk factors of coronary artery stenosis;atherosclerosis of coronary artery;stenosis degree;coronary angiography

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 胡战;方颖;
HU Zhan;FANG Ying;Guizhou Medical University;

Email:

DOI: 10.19367/j.cnki.1000-2707.2015.12.030

参考文献(References)：

• [1]葛均波,徐永健,等.内科学第八版[M].北京:人民卫生出版社,2013:227.
• [2]Talmor Y,Golan E,Benchetrit S,et al.Calcitriolblunts the deleterious in pact of adv-anced glycation end products on endothelial cells[J].Am J Physiol Renal Physiol,2008(5):1059-064.
• [3]Talmor Y,Golan E,Benchetrit S,et al.Calcitril blunts pro-atherosclerotic parameters t-hrough NFkappa B and p38 in vitro[J].Eur J Clin Invest,2008(8):548-554.
• [4]Mantell DJ,Owens PE,Bundred NJ,et al.1-alpha,25-dihydroxyvitamin D3 inhibits a-ngiogenesis in vitro and in vivo.Circ Res,2000(87):214-220.
• [5]Yamamoto T,Kozawa O,Tanabe K,et al.1,25-dihydroxyvitamin stimulates Vascul-ar endothelial growth factor release in aorticsmooth muscle cell:role of p38 mitogen-activated protein kinase[J].Arch Biochem Biophys,2002(1):1-6.
• [6]Amer M,Qayyum R.Relation between serum 25-hydroxyvitamin D and C-reactive protein in asympto-matic adults(from the continuous National Healthand Nutrition Exa mination Survey 2001 to 2006)[J].Am J Cardiol,2012(2):226-230.
• [7]Ohsawa M,Koyama T,Yamamoto K,et al.1 alpha,25-dihydroxyvitamin D3 and its potent synthetic analogs downregulate tissue factor and up regulate thrombomdulin expression in monocytic cel1s,counteracting the effects of tumor necrosis factor and oxidized LDL[J].Cir-culation,2000(23):2867-2872.
• [8]Absi M,Ward DT.Increased endothelin-1 responsiveness in human coronary artery smo-oth muscle cells exposed to1,25-dihydroxyvitamin D(3)[J].Am J Physiol Cell Physio l,2013(7):666-672.
• [9]Oz F,Cizgici AY,Oflaz H.Impact of vitamin D insufficiency on the epicardial coronary fl-ow velocity and endothelial function[J].Coron Artery Dis,2013(5):392-397.
• [10]Matias PJ,Ferreira C,Jorge C,et al.25-Hydroxyvitamin D3,arterial calci Fications a-nd cardiovascular risk markers in haemodialysis patients[J].Nephrol Dial Transplant,2009,24(2):611-618
• [11]Mathieu C,Gysemans C,Giulietti A,el al.Vitamin D and diabetes[J].Oiabetologia,2005(7):1247-1257.
• [12]Pittas AG,Harris SS,Stark PC,et al.The effects of calcium and vitamin D supplem-entation on blood glucose and makers of inflammation in nondiabetic adults[J].Diabetes Care,2007(4):980-986.
• [13]邹敏书,余健,聂国明,等.维生素D对高糖诱导足细胞胰岛素抵抗的保护作用[J].临床儿科杂志,2014(5):471-475.
• [14]Scragg R,Sowerers M,Bell C.Serum 25-hydroxyvitamin D,ethnicity,and blood press-ure in the Third National Health and Nutrition Examination Survey[J].Am JHypertens,2007(7):713-719.
• [15]Li YC,Kong J,Wei M,et al.1,25-dihydroxyvitamin D3is a negative endocrine regul-ator of the renin-angiotensin system[J].J Clin Invest,2002(2):229-238.
• [16]Wong MS,DelansorneR,ManRY,et al.Vitamin D derivatives acutely reduce endotheli-umdepend contractions in the aorta of spontaneously hypertensive rat[J].Am JP hysiol Heart Circ Physiol,2008(1):H289-H296.
• [17]汪英,袁莉,李广利,等.肥胖与血清维生素D水平的关系研究[J]中华内分泌代谢杂志,2011(7):589-590.

文章评论(Comment)：